ClinicalTrials.gg
Drug

Tamibarotene clinical trials

Also written Am80 and SY-1425.

studies test it
16
open now
2
in phase 3
2
first study started
2006

How each study uses tamibarotene is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the tamibarotene studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Tamibarotene
14

Development codes

Am80
3
SY-1425
2

Studies by the year they started

16 studies that test it; most in 2021 (3)

Studies that test tamibarotene, by start year
YearStudies
20061
20071
20081
20091
20102
20112
20161
20213
20232
20251
20261

Who runs them

Industry 8 · Other 8

Nagoya University (3) · Syros Pharmaceuticals (3) · CytRx (2) · Rege Nephro Co., Ltd. (1) · Zeria Pharmaceutical (1) · R&R Inc. (1) · St. Marianna University School of Medicine (1) · Northwestern University (1)

Often tested with

Tested in the same studies.

Azacitidine (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test tamibarotene.

Studies

Open first, then newest update. How each study uses tamibarotene is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 16

What changed recently

From the registry's own updates since Oct 20, 2026.

Codes

What other systems call tamibarotene · ClinicalTrials.gg INT003463

  • MeSH (NLM) C061133tamibaroteneOne source NLM
  • UNII (FDA) 08V52GZ3H9TAMIBAROTENEConfirmed FDA, NLM, Wikidata
  • Wikidata Q7681221tamibaroteneConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C71025TamibaroteneOne source FDA
  • DrugBank DB04942One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.